Sector: Healthcare|Industry: Drug Manufacturers - General|Market Cap: $22.18B|Employees: 7.6K
Biogen is a global biopharmaceutical company focused on discovering, developing, and delivering innovative therapies for people living with serious and complex diseases. The company's core business model centers around developing treatments for neurological, specialized immunology, and rare diseases, with primary revenue streams derived from sales of its marketed products and collaborations. Biogen has a significant geographic presence in the U.S., Europe, and Japan.
Detailed Profile